CLINICAL ROLE -
COVID-19 Pandemic Brought Changes, Requiring Significant Adjustments in Health Systems
Pandemic-related growing pains were common within health care, bringing unique challenges for health systems.
Insights, Future Considerations in FLT3 Inhibitors Following Allo-HCT in Patients With AML
In this NCCN session, James M. Foran, MD, described the different FLT3 inhibitors that are available for FLT3-mutated AML, as well as considerations for the future.
New, Emerging Treatment Options for Patients With Multiple Myeloma
In addition to emerging treatment options, the speakers addressed the importance of individualized decision-making when treating patients with multiple myeloma.
